CLX
The Clorox CompanyNYSEConsumer Defensive$101.14-2.97%OpenMarket Cap: $12.34B
As of 2026-04-06
Valuation
P/E (TTM)
16.34
PEG
0.25
P/B
-98.39
P/S
1.83
EV/EBITDA
11.66
DCF Value
$328.24
FCF Yield
6.3%
Div Yield
4.9%
Margins & Returns
Gross Margin
44.0%
Operating Margin
15.2%
Net Margin
11.2%
ROE
1502.5%
ROA
17.4%
ROIC
21.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $1.67B | 43.2% | $241.0M | $157.0M | $1.29 | $1.24 |
| Q1 2026 | $1.43B | 41.6% | $123.0M | $80.0M | $0.65 | $1.24 |
| Q4 2025 | $1.99B | 46.3% | $422.0M | $332.0M | $2.68 | $1.22 |
| FY 2025 | $7.10B | 45.0% | $1.18B | $810.0M | $6.52 | $4.88 |
| Q3 2025 | $1.67B | 44.3% | $238.0M | $186.0M | $1.50 | $1.22 |
| Q2 2025 | $1.69B | 43.6% | $233.0M | $193.0M | $1.54 | $1.22 |
| Q1 2025 | $1.76B | 45.9% | $295.0M | $99.0M | $0.79 | $1.22 |
| Q4 2024 | $1.90B | 46.2% | $320.0M | $216.0M | $1.73 | $1.20 |
| FY 2024 | $7.09B | 42.6% | $916.0M | $280.0M | $2.25 | $4.80 |
| Q3 2024 | $1.81B | 42.0% | $218.0M | $-51.0M | $-0.41 | $1.20 |
| Q2 2024 | $1.99B | 43.2% | $322.0M | $93.0M | $0.75 | $1.20 |
| Q1 2024 | $1.39B | 38.5% | $64.0M | $22.0M | $0.18 | $1.20 |